INS and Hypoglycemia: The HypoAna Trial—a multicenter, prospective, randomized, open, blinded-endpoint cross-over study—from 2012 examined the difference in the occurrence of severe hypoglycemia during treatment with insulin detemir and insulin aspart (analog insulins) compared to NPH insulin and human regular insulin (human insulins) (Kristensen et al., 2012b).